Source: Fierce Biotech Jazz Pharmaceuticals has drummed up a deal in double time, agreeing to buy Chimerix for $935 million…...
Latest News

FDA blesses atopic dermatitis label expansions for Organon’s Vtama, Galderma’s Nemluvio
Source: FiercePharma The FDA has blessed two previously approved medicines—one a cream and the other an injection—to treat atopic dermatitis…...

Organon pays up to $1.2B to acquire Dermavant and its steroid-free skin cream Vtama
Source: FiercePharma With its latest acquisition, women’s health outfit Organon is bringing its dermatology business to the U.S. with a…...

Incyte, fresh off gaining MorphoSys drug, buys Escient for $750M
Source: Fierce Biotech Incyte is dolloping another deal onto its 2024 partnership plate, buying San Diego-based Escient Pharmaceuticals for $750…...

LEO Pharma to Acquire Timber Pharmaceuticals
Source: Dermatology Times LEO Pharma announced today its acquisition of Timber Pharmaceuticals, a transaction valued at $36 million.1 Timber Pharmaceuticals has…...

Rick Beck – Founding Recruiter on Forbes.jobs
Meet Rick Beck, a highly respected executive recruiter with a passion for connecting top talent with leading companies in the pharmaceutical,…...

L’Oreal to acquire skinbetter science
Clichy, September 23, 2022 – L’Oréal signed an agreement to acquire Skinbetter Science, a physician-dispensed American skincare brand backed by cutting-edge, dermatological…...

EPI Health Announces Acquisition by Novan, Inc. to Create Fully Integrated Specialty Dermatology Company
Source: EPI Health The EP Group (privately held parent company of EPI Health, Inc.) today announced the acquisition of EPI…...

Journey Medical Corporation Acquires Two FDA-Approved Topical Minocycline Products and Molecule Stabilizing Technology (MST)™ Franchise from VYNE Therapeutics, Inc.
Source: GlobeNewswire Journey Medical Corporation (NASDAQ: DERM) (“Journey Medical”), a commercial-stage pharmaceutical company that focuses on the development and commercialization…...

Journey Medical Corporation Announces Launch of its Initial Public Offering
Source: GlobesNewswire Journey Medical Corporation (“Journey Medical”), a commercial-stage pharmaceutical company that focuses on the development and commercialization of pharmaceutical…...